New Canadian guidance on opioid use for chronic pain: necessary but not sufficient
- PMID: 28483843
- PMCID: PMC5422147
- DOI: 10.1503/cmaj.170431
New Canadian guidance on opioid use for chronic pain: necessary but not sufficient
Conflict of interest statement
Competing interests: Owen Williamson reports nonfinancial support from Health Canada and personal fees and nonfinancial support from Purdue Pharma (Canada), Mundipharma International Ltd. and INVIVO Communications Ltd., outside the submitted work. Andrea Furlan is acknowledged in the guideline published in this issue of CMAJ. She participated in the first meeting of the clinical experts in January 2016 but was not involved in the remaining development of the guideline.
Comment in
-
Role of regulators in safe prescribing of opioids.CMAJ. 2017 Sep 18;189(37):E1195. doi: 10.1503/cmaj.733125. CMAJ. 2017. PMID: 28923799 Free PMC article. No abstract available.
-
Response to "Role of regulators in safe prescribing of opioids".CMAJ. 2017 Sep 18;189(37):E1196. doi: 10.1503/cmaj.733208. CMAJ. 2017. PMID: 28923800 Free PMC article. No abstract available.
Comment on
-
Guideline for opioid therapy and chronic noncancer pain.CMAJ. 2017 May 8;189(18):E659-E666. doi: 10.1503/cmaj.170363. CMAJ. 2017. PMID: 28483845 Free PMC article. No abstract available.
References
-
- Gomes T, Juurlink D, Moineddin R, et al. Geographical variation in opioid prescribing and opioid-related mortality in Ontario. Healthc Q 2011;14:22–4. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical